BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,611,760 | -29.7% | 1,450,239 | +53.0% | 0.01% | -33.3% |
Q4 2022 | $6,557,440 | +775.5% | 947,607 | +700.8% | 0.02% | +800.0% |
Q3 2022 | $749,000 | +98.7% | 118,333 | +30.0% | 0.00% | +100.0% |
Q2 2022 | $377,000 | -69.9% | 91,028 | +215.0% | 0.00% | -85.7% |
Q4 2020 | $1,251,000 | -93.2% | 28,900 | -91.6% | 0.01% | -94.8% |
Q3 2020 | $18,452,000 | +710.4% | 342,014 | +1810.4% | 0.14% | +800.0% |
Q2 2019 | $2,277,000 | -77.6% | 17,903 | -72.3% | 0.02% | -77.9% |
Q1 2019 | $10,185,000 | +15.0% | 64,738 | -27.5% | 0.07% | +6.2% |
Q4 2018 | $8,857,000 | -74.3% | 89,281 | -62.1% | 0.06% | -59.0% |
Q3 2018 | $34,425,000 | -44.8% | 235,787 | -40.6% | 0.16% | -44.9% |
Q2 2018 | $62,339,000 | +12.8% | 397,190 | +22.8% | 0.28% | +23.0% |
Q1 2018 | $55,244,000 | +54.7% | 323,539 | +61.3% | 0.23% | +105.4% |
Q4 2017 | $35,715,000 | -60.2% | 200,533 | -69.3% | 0.11% | -68.2% |
Q3 2017 | $89,707,000 | +119.4% | 653,122 | +67.8% | 0.35% | +108.3% |
Q2 2017 | $40,883,000 | -23.8% | 389,181 | -34.1% | 0.17% | -32.4% |
Q1 2017 | $53,665,000 | +23.2% | 590,378 | -16.4% | 0.25% | +6.8% |
Q4 2016 | $43,562,000 | +17.1% | 706,035 | +28.7% | 0.23% | +8.8% |
Q3 2016 | $37,190,000 | +281.6% | 548,684 | +143.7% | 0.22% | +241.3% |
Q2 2016 | $9,747,000 | +6.3% | 225,167 | +4.4% | 0.06% | +16.7% |
Q1 2016 | $9,166,000 | +6.3% | 215,660 | +60.6% | 0.05% | -10.0% |
Q4 2015 | $8,622,000 | +2055.5% | 134,261 | +2768.8% | 0.06% | +1900.0% |
Q3 2015 | $400,000 | – | 4,680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |